Major players in the multiplex assays market include Luminex Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and QIAGEN N.V. (Netherlands).
In 2016, the global multiplex assays market is dominated by Luminex Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), owing to their global presence and broad product portfolio in the global multiplex assays market.
Among the top five players in the multiplex assays market, Luminex Corporation (U.S.) held the largest share of 30% in 2016. Over the past three years, Luminex adopted the strategies of approvals, new product launches, acquisition, agreement, and collaborations to maintain its position in the global multiplex assays market. In June 2016, Luminex received approval for marketing its ARIES M1 System in the U.S. and European Union. The Aries M1 System is a new in vitro diagnostic system for smaller labs that features an intuitive system interface, STAT or batch testing, and higher walkaway times. This enhanced the company’s portfolio.
Thermo Fisher, a global multiplex assays providing company, offers instruments & accessories, multiplex master mixes, immunoassays, and custom Luminex assays. In order to maintain its dominance in the multiplex assays market, the company primarily adopts the strategies of acquisitions. In May 2016, Thermo Fisher Scientific Inc. acquired Affymetrix, Inc. (U.S.), a pioneer in microarrays and genomic analysis. This acquisition provided Thermo Fisher Scientific with technologies and systems that allow multiplex and parallel analysis of biological systems at the cellular, protein, and genetic levels.
The multiplex assays market is in different phases of growth in different regions. In the U.S. and Europe, the multiplex assays market is in a mature phase with several key players opting to reduce the run time of sample analysis and increase reproducible analysis of multiple analytes.
Companies in the multiplex assays market are majorly focusing on new product launches and this strategy accounted for 42% of the total number of developments adopted by key players in this market.
Multiplex Assays Market – Product (Consumables, Software and Services), Type (Nucleic Acid, Protein), Technology (PCR, Bead-Based Arrays), Application (R&D, Companion Diagnostics), End User (Pharma & Biotech, Clinical Laboratory) – Global Forecast to 2021
Multiplex Assays Market – Product (Consumables, Instruments), Type (Nucleic acid, Protein), Technology (PCR, Multiplex Arrays), Application (R&D, Disease and Disorder), End User (Pharma & Biotech, Academic & Research Institutes) – Global Forecast to 2021